Literature DB >> 8782251

Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter.

S P Hume1, S K Luthra, D J Brown, J Opacka-Juffry, S Osman, S Ashworth, R Myers, F Brady, F I Carroll, M J Kuhar, D J Brooks.   

Abstract

The cocaine analogue RTI-121 (3 beta-(4-iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester), when labeled with carbon-11, was evaluated in rats as a potential PET ligand for the dopamine transporter. The compound gave in vivo striatum:cerebellum ratios that were similar to those obtained with the related ligand [11C]RTI-55 (2 beta-(4-iodophenyl)tropane-2 beta-carboxylic acid methyl ester) but showed a much greater selectivity for the dopamine compared with the 5-HT uptake site. The results indicate that [11C]RTI-121 could be used in preference to [11C]RTI-55 in man. Experimentally, [11C]RTI-121 has potential in the quantification of dopamine terminal function in rat models of disease, using a combination of autoradiography, postmortem sampling, and in vivo tomography.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782251     DOI: 10.1016/0969-8051(96)00019-4

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  1 in total

1.  Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum. Short communication.

Authors:  J Opacka-Juffry; S Ashworth; A M Sullivan; R B Banati; S B Blunt
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.